SCHEMBL3432306

SCHEMBL3432306

[CH2]CCc1cc(Br)ccc1I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29133633 0.83 TSHR (0.31)
SCHEMBL3366223 0.79 CHEK1 (0.38)
SCHEMBL26586653 0.79
SCHEMBL136444 0.76 CHEK1 (0.40)
SCHEMBL17376656 0.76 TYR (0.39)
SCHEMBL30087221 0.76 CYP2A6 (0.32)
SCHEMBL2556376 0.76 CYP2A6 (0.32)
SCHEMBL12097459 0.74 CCR5 (0.31)
SCHEMBL9939277 0.74 CYP2A6 (0.44)
SCHEMBL31088263 0.74 SMN1; SMN2 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2257524-A1 N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS Amira Pharmaceuticals, Inc. (US) 2010-12-08 EP disclosed
WO-2009099902-A1 N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS AMIRA PHARMACEUTICALS, INC. (US) 2009-08-13 WO disclosed